3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
77
Pancreatic Neoplasms
56
Stomach Neoplasms
52
Rectal Neoplasms
43
Esophageal Squamous Cell Carcinoma
38
Esophageal Neoplasms
38
Neoplasm Metastasis
25
Colonic Neoplasms
23
Neoplasms
15
Cholangiocarcinoma
13
Liver Neoplasms
10
Gastrointestinal Neoplasms
10
Breast Neoplasms
9
Adenocarcinoma Of Esophagus
9
Carcinoma, Hepatocellular
7
Anus Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Biliary Tract Neoplasms
6
Ovarian Neoplasms
5
Melanoma
5
Adenocarcinoma
5
Kidney Neoplasms
4
Gastrointestinal Diseases
4
Digestive System Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Lymphoma
3
Interventions
Docetaxel
4
Cetuximab
4
pembrolizumab
3
Trastuzumab
3
Magnetic Resonance Spectroscopy
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Biopsy
3
trastuzumab deruxtecan
2
sargramostim
2
Taxes
2
SS1(dsFv)PE38
2
Radiotherapy
2
Polymerase Chain Reaction
2
Immunohistochemistry
2
Gene Expression Profiling
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
tanespimycin
1
spartalizumab
1
pertuzumab
1
oncogene protein E7, Human papillomavirus type 16
1
neratinib
1
mercaptoundecahydrododecaborate
1
larotrectinib
1
fluoromisonidazole
1
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Drug Therapy
×
Gastrointestinal
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled